Literature DB >> 27346321

Epigenetic basis of sensitization to stress, affective episodes, and stimulants: implications for illness progression and prevention.

Robert M Post1.   

Abstract

OBJECTIVES: The process of sensitization (increased responsivity) to the recurrence of stressors, affective episodes, and bouts of substance abuse that can drive illness progression in the recurrent affective disorders requires a memory of and increased reactivity to the prior exposures. A wealth of studies now supports the postulate that epigenetic mechanisms underlie both normal and pathological memory processes.
METHODS: We selectively reviewed the literature pertinent to the role of epigenetics in behavioral sensitization phenomena and discuss its clinical implications.
RESULTS: Epigenetics means above genetics and refers to environmental effects on the chemistry of DNA, histones (around which DNA is wound), and microRNA that change how easily genes are turned on and off. The evidence supports that sensitization to repeated stressor, affective episodes, and substance is likely based on epigenetic mechanisms and that these environmentally based processes can then become targets for prevention, early intervention, and ongoing treatment. Sensitization processes are remediable or preventable risk factors for a poor illness outcome and deserve increased clinical, public health, and research attention in the hopes of making the recurrent unipolar and bipolar affective disorders less impairing, disabling, and lethal by suicide and increased medical mortality.
CONCLUSIONS: The findings that epigenetic chemical marks, which change in the most fundamental way how genes are regulated, mediate the long-term increased responsivity to recurrent stressors, mood episodes, and bouts of substance abuse should help change how the affective disorders are conceptualized and move treatment toward earlier, more comprehensive, and sustained pharmacoprophylaxis.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  DNA; bipolar disorder; depression; drug abuse; histones; kindling; pharmacotherapy; prevention; sensitization; stress

Mesh:

Substances:

Year:  2016        PMID: 27346321     DOI: 10.1111/bdi.12401

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  17 in total

1.  Interactions of immediate and long-term action regulation in the course and complications of bipolar disorder.

Authors:  Marijn Lijffijt; Brittany O'Brien; Ramiro Salas; Sanjay J Mathew; Alan C Swann
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-02-18       Impact factor: 6.237

2.  Myriad of implications of acetyl-l-carnitine deficits in depression.

Authors:  Robert M Post
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-01       Impact factor: 11.205

3.  Staging in bipolar disorder: from theoretical framework to clinical utility.

Authors:  Michael Berk; Robert Post; Aswin Ratheesh; Emma Gliddon; Ajeet Singh; Eduard Vieta; Andre F Carvalho; Melanie M Ashton; Lesley Berk; Susan M Cotton; Patrick D McGorry; Brisa S Fernandes; Lakshmi N Yatham; Seetal Dodd
Journal:  World Psychiatry       Date:  2017-10       Impact factor: 49.548

4.  The Kindling/Sensitization Model and Early Life Stress.

Authors:  Robert M Post
Journal:  Curr Top Behav Neurosci       Date:  2021

5.  The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management.

Authors:  Roger S McIntyre; Martin Alda; Ross J Baldessarini; Michael Bauer; Michael Berk; Christoph U Correll; Andrea Fagiolini; Kostas Fountoulakis; Mark A Frye; Heinz Grunze; Lars V Kessing; David J Miklowitz; Gordon Parker; Robert M Post; Alan C Swann; Trisha Suppes; Eduard Vieta; Allan Young; Mario Maj
Journal:  World Psychiatry       Date:  2022-10       Impact factor: 79.683

Review 6.  Corneal pain and experimental model development.

Authors:  Tina B McKay; Yashar Seyed-Razavi; Chiara E Ghezzi; Gabriela Dieckmann; Thomas J F Nieland; Dana M Cairns; Rachel E Pollard; Pedram Hamrah; David L Kaplan
Journal:  Prog Retin Eye Res       Date:  2018-11-16       Impact factor: 21.198

7.  Does the number of previous mood episodes moderate the relationship between alcohol use, smoking and mood in bipolar outpatients?

Authors:  Wendela G Ter Meulen; Jan van Zaane; Stasja Draisma; Aartjan T F Beekman; Ralph W Kupka
Journal:  BMC Psychiatry       Date:  2017-05-15       Impact factor: 3.630

8.  Dehydroevodiamine·HCl enhances cognitive function in memory-impaired rat models.

Authors:  Ki Young Shin; Ka Young Kim; Yoo-Hun Suh
Journal:  Korean J Physiol Pharmacol       Date:  2016-12-21       Impact factor: 2.016

Review 9.  Translational evidence for lithium-induced brain plasticity and neuroprotection in the treatment of neuropsychiatric disorders.

Authors:  Stefano Puglisi-Allegra; Stefano Ruggieri; Francesco Fornai
Journal:  Transl Psychiatry       Date:  2021-07-05       Impact factor: 6.222

Review 10.  The New News about Lithium: An Underutilized Treatment in the United States.

Authors:  Robert M Post
Journal:  Neuropsychopharmacology       Date:  2017-10-04       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.